Blogs About
Digital Innovations & HIT Interoperability

OptimizeRx’s EHR Network: Insights from DxWeb’s Dr. Jeffrey Stahl
Life science manufacturers’ interest in EHR-based solutions for HCP engagement is growing, but the recent and rapid growth in the market means that navigating various...

HCP Engagement and the Sales Rep: Enabling Face-to-Face Connections
HCP engagement in the digital marketing era
Sales representatives have long been a vital ingredient in life science companies' HCP engagement strategies – educating...

Insights from the “Data Ninjas” – Advancing Omnichannel with Real-World Data
Unlocking the Full Potential of Real-World Data
Real-World Data (RWD) has become an integral, inseparable element of omnichannel marketing (OCM), which is an increasingly...

What’s Your Market Access Digital Maturity?
When pharma brands become fully digitally enabled, market access pathways are optimized and providers have the tools they need to begin patients on your therapy rapidly and...

Strengthening HCP Engagement with Omnichannel Strategies
During the recent Digital Pharma Innovation Week, I had the great opportunity to lead a roundtable discussion with a group of stakeholders from across the pharma industry...

Making the Case for a Digital Revolution in Market Access
As pharmaceutical companies evolve toward digital-first commercial models, U.S. market access strategies seem to be lagging in the digital revolution. Companies face many...

Help HCPs Keep Patients on Course with a Precision Engagement Approach
Non-adherence to prescribed therapy can create extraordinary risks for patients. Even when provided with correct diagnoses and effective treatment plans, patients can often...

Inefficient Access Pathways Cost More Than Just HCP Time and Effort
There may be no greater threat to patient outcomes than the current barriers to therapy access—especially for specialty medications.

A Digital Point-of-Care Primer for Life Science Marketers
Growth in healthcare technology began with the HITECH (Health Information Technology for Economic and Clinical Health) Act of 2009 and has grown significantly over the years....

Connect With Providers When Their Patients Need to Change Therapies
Every day, patients need to switch to new therapies because of disease progression, side effects, affordability or other factors—and if your brand is a second- or third-, or...

The RWD Win/Win: A Strategy that Delivers for Pharma, Patients, HCPs and More
Over the past decade, pharma has made significant investments in real-world data (RWD) and in analytics/insights generated from that data -- real-world evidence (RWE). At ...